Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids

ACS Chemical Neuroscience
Mathew Harry HorrocksDavid Klenerman

Abstract

The misfolding and aggregation of proteins into amyloid fibrils characterizes many neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. We report here a method, termed SAVE (single aggregate visualization by enhancement) imaging, for the ultrasensitive detection of individual amyloid fibrils and oligomers using single-molecule fluorescence microscopy. We demonstrate that this method is able to detect the presence of amyloid aggregates of α-synuclein, tau, and amyloid-β. In addition, we show that aggregates can also be identified in human cerebrospinal fluid (CSF). Significantly, we see a twofold increase in the average aggregate concentration in CSF from Parkinson's disease patients compared to age-matched controls. Taken together, we conclude that this method provides an opportunity to characterize the structural nature of amyloid aggregates in a key biofluid, and therefore has the potential to study disease progression in both animal models and humans to enhance our understanding of neurodegenerative disorders.

References

Jan 1, 1997·Annual Review of Biophysics and Biomolecular Structure·M J Saxton, K Jacobson
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·J BieschkeH Kretzschmar
Mar 21, 2003·The Journal of Biological Chemistry·Tadato BanYuji Goto
Jun 9, 2004·Journal of Molecular Biology·Wolfgang HoyerThomas M Jovin
Nov 10, 2004·Journal of Molecular Biology·Tadato BanYuji Goto
Dec 21, 2004·Nature Neuroscience·James P ClearyKaren H Ashe
Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Jun 8, 2006·Annual Review of Biochemistry·Fabrizio Chiti, Christopher M Dobson
Jun 14, 2006·Langmuir : the ACS Journal of Surfaces and Colloids·Chiaki Yoshina-IshiiSteven G Boxer
Aug 26, 2006·Biochemical and Biophysical Research Communications·Takahiko TokudaOmar M A El-Agnaf
Feb 20, 2007·Journal of Proteome Research·Alexander A MaskevichKonstantin K Turoverov
Oct 30, 2007·Biochemical and Biophysical Research Communications·Susanne Aileen FunkeDieter Willbold
Apr 3, 2008·PloS One·Tiago Fleming OuteiroPamela J McLean
Apr 25, 2008·Journal of Molecular Biology·Shyamala ThirunavukkuarasuThomas M Jovin
Dec 17, 2008·Brain Research·Moeko Noguchi-ShinoharaMasahito Yamada
Feb 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Robert M KoffieTara L Spires-Jones
Apr 20, 2010·Biochimica Et Biophysica Acta·Matthew Biancalana, Shohei Koide
Feb 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Beate WinnerRoland Riek
Oct 31, 2012·Biochemistry·Priyanka NarayanDavid Klenerman
Apr 11, 2014·Biochemistry·Priyanka NarayanDavid Klenerman
Sep 17, 2014·Natural Product Reports·Tim WezemanKye-Simeon Masters
Jan 16, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·N K MagdalinouH Zetterberg
Apr 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·Serene W ChenNunilo Cremades
May 1, 2015·Nature Communications·Sarah L ShammasDavid Klenerman

❮ Previous
Next ❯

Citations

Jun 3, 2016·Physical Chemistry Chemical Physics : PCCP·Suzanne K Shoffner, Santiago Schnell
Aug 9, 2016·Biochimica Et Biophysica Acta·Claire SchirmerCyrille Garnier
Feb 1, 2018·The Journal of Biological Chemistry·Dezerae CoxHeath Ecroyd
Jan 18, 2018·Angewandte Chemie·Juan A VarelaSteven F Lee
Jul 12, 2018·Chemical Communications : Chem Comm·Kevin J Cao, Jerry Yang
Jul 28, 2018·Chembiochem : a European Journal of Chemical Biology·Daniel R WhitenMathew H Horrocks
Mar 9, 2018·Royal Society Open Science·Lisa-Maria NeedhamSteven F Lee
Jan 4, 2019·Current Protein & Peptide Science·Botond PenkeLívia Fülöp
Sep 20, 2020·Protein Science : a Publication of the Protein Society·Curran OiLynne Regan
Dec 13, 2019·Nature Communications·James W P BrownYann Gambin
Nov 30, 2018·Acta Neuropathologica·José Luis MolinuevoKaj Blennow
Sep 22, 2020·Chemical Science·Alexander J DearTuomas P J Knowles
Nov 6, 2020·Quarterly Reviews of Biophysics·Jinming WuJinghui Luo
Dec 8, 2020·Chemical Society Reviews·Liqian GaoShao Q Yao
Nov 22, 2020·Biophysical Chemistry·Emma E CawoodSheena E Radford
Jun 17, 2020·Methods : a Companion to Methods in Enzymology·Lara DresserSteven D Quinn
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jie YangSi Wu
Mar 12, 2021·Neurobiology of Disease·John S H Danial, David Klenerman
May 1, 2021·International Journal of Molecular Sciences·Yiyun JinFrancesco Antonio Aprile
Feb 21, 2020·Chemical Science·Lisa-Maria NeedhamSteven F Lee
Mar 29, 2018·ACS Chemical Neuroscience·Franziska KundelDavid Klenerman
Nov 24, 2020·ACS Chemical Neuroscience·Nicholas R MarzanoHeath Ecroyd
Jul 31, 2018·Analytical Chemistry·Christopher G TaylorDavid Klenerman
Sep 15, 2020·The Journal of Physical Chemistry Letters·Lisa-Maria NeedhamSteven F Lee
Jun 29, 2018·ACS Chemical Neuroscience·Magnus KjaergaardDavid Klenerman
Oct 30, 2018·ACS Nano·Marija IljinaDavid Klenerman
Oct 24, 2018·Journal of the American Chemical Society·Jason C SangDavid Klenerman

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
atomic
dynamic
circular dichroism
AFM
ELISA

Software Mentioned

SAVE

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.